// App-Quantinova.ai

4088 : Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention.

Researchers

Presenter

  • Maeve Aine Lowery

Principal Investigators

  • Emmet Jordan

  • Michael F. Berger

  • Ahmet Zehir

  • Nancy E. Kemeny

  • Eileen Mary O'Reilly

  • William R. Jarnagin

  • James J. Harding

  • Ronald P. DeMatteo

  • Michael Ian D'Angelica

  • Andrea Cercek

  • Michele LY

  • Erica Salehi

  • Jaclyn Frances Hechtman

  • Nikolaus Schultz

  • David Michael Hyman

  • David S. Klimstra

  • Leonard Saltz

  • Ghassan K. Abou-Alfa

Medical Centers

  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved